Rockwell Medical Announces $55 Million Proposed Public Offering of Common Stock

WIXOM, Mich. -- Rockwell Medical, Inc. , a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for ...



from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1wPHUhv

via IFTTT